23 results on '"Matano, Tetsuro"'
Search Results
2. In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.
- Author
-
Seki, Sayuri, Nomura, Takushi, Nishizawa, Masako, Yamamoto, Hiroyuki, Ishii, Hiroshi, Matsuoka, Saori, Shiino, Teiichiro, Sato, Hironori, Mizuta, Kazuta, Sakawaki, Hiromi, Miura, Tomoyuki, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
MICROBIAL virulence ,PATHOGENIC microorganisms ,HISTOCOMPATIBILITY antigens ,CELL lines ,HIV infections - Abstract
CD8
+ T-cell responses exert strong suppressive pressure on HIV replication and select for viral escape mutations. Some of these major histocompatibility complex class I (MHC-I)-associated mutations result in reduction of in vitro viral replicative capacity. While these mutations can revert after viral transmission to MHC-I-disparate hosts, recent studies have suggested that these MHC-I-associated mutations accumulate in populations and make viruses less pathogenic in vitro. Here, we directly show an increase in the in vivo virulence of an MHC-I-adapted virus serially-passaged through MHC-I-mismatched hosts in a macaque AIDS model despite a reduction in in vitro viral fitness. The first passage simian immunodeficiency virus (1pSIV) obtained 1 year after SIVmac239 infection in a macaque possessing a protective MHC-I haplotype 90-120-Ia was transmitted into 90-120-Ia- macaques, whose plasma 1 year post-infection was transmitted into other 90-120-Ia- macaques to obtain the third passage SIV (3pSIV). Most of the 90-120-Ia-associated mutations selected in 1pSIV did not revert even in 3pSIV. 3pSIV showed lower in vitro viral fitness but induced persistent viremia in 90-120-Ia- macaques. Remarkably, 3pSIV infection in 90-120-Ia+ macaques resulted in significantly higher viral loads and reduced survival compared to wild-type SIVmac239. These results indicate that MHC-I-adapted SIVs serially-transmitted through MHC-I-mismatched hosts can have higher virulence in MHC-I-matched hosts despite their lower in vitro viral fitness. This study suggests that multiply-passaged HIVs could result in loss of HIV-specific CD8+ T cell responses in human populations and the in vivo pathogenic potential of these escaped viruses may be enhanced. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
3. Broadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers.
- Author
-
Nomura, Takushi, Yamamoto, Hiroyuki, Ishii, Hiroshi, Akari, Hirofumi, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
CD8 antigen ,CD antigens ,T cells ,LYMPHOCYTES ,VIRAL replication - Abstract
Control of HIV replication is a rare immunological event, providing clues to understand the viral control mechanism. CD8
+ T-cell responses are crucial for virus control, but it is unclear whether lasting HIV containment can be achieved after establishment of infection. Here, we describe lasting SIV containment in a macaque AIDS model. Analysis of ten rhesus macaques that controlled viremia for 2 years post-infection found accumulation of proviral gag and nef CD8+ T-cell escape mutations in four of them. These four controllers mounted CD8+ T cells targeting Gag, Nef, and other viral proteins at 4 months, suggesting that broadening of CD8+ T-cell targets can be an indicator of the beginning of viral control failure. The remaining six aviremic SIV controllers, however, harbored proviruses without mutations and showed no or little broadening of their CD8+ T-cell responses in the chronic phase. Indeed, three of the latter six exhibiting no change in CD8+ T-cell targets showed gradual decreases in SIV-specific CD8+ T-cell frequencies, implying a concomitant reduction in viral replication. Thus, stability of the breadth of virus-specific CD8+ T-cell responses may represent a status of lasting HIV containment by CD8+ T cells. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
4. Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates.
- Author
-
Ohtani, Hitoshi, Naruse, Taeko, Iwasaki, Yuki, Akari, Hirofumi, Ishida, Takafumi, Matano, Tetsuro, and Kimura, Akinori
- Subjects
T cells ,IMMUNOGLOBULINS ,MUCIN genetics ,PRIMATE physiology ,IMMUNE response ,NATURAL selection ,MOLECULAR evolution ,PSEUDOGENES - Abstract
T-cell immunoglobulin domain and mucin domain containing protein 1 (TIM1), also known as a cellular receptor for hepatitis A virus (HAVCR1) or a molecule induced by ischemic injury in the kidney (KIM1), is involved in the regulation of immune responses. We investigated a natural selection history of TIM1 by comparative sequencing analysis in 24 different primates. It was found that TIM1 had become a pseudogene in multiple lineages of the New World monkey. We also investigated T cell lines originated from four different New World monkey species and confirmed that TIM1 was not expressed at the mRNA level. On the other hand, there were ten amino acid sites in the Ig domain of TIM1 in the other primates, which were suggested to be under positive natural selection. In addition, mucin domain of TIM1 was highly polymorphic in the Old World monkeys, which might be under balanced selection. These data suggested that TIM1 underwent a lineage-specific evolutionary pathway in the primates. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. ULBP4/RAET1E is highly polymorphic in the Old World monkey.
- Author
-
Naruse, Taeko, Okuda, Yukiko, Mori, Kazuyasu, Akari, Hirofumi, Matano, Tetsuro, and Kimura, Akinori
- Subjects
IMMUNOGENETICS ,KRA ,RHESUS monkeys ,IMMUNE response ,GENETIC polymorphisms ,MONOCLONAL antibodies ,T cells ,ANIMAL models in research - Abstract
Natural-killer group 2 member D (NKG2D) is an activating receptor that plays an important role in the immune response mediated by NK cells, γδ T cells, and CD8 T cells. In humans, MHC class I chain-related genes and UL-16 binding protein (ULBP)/retinoic acid early transcript 1 (REAT1) gene family encode ligands for NKG2D. The rhesus and crab-eating macaques, which belong to the Old World monkeys, are widely used as non-human primate models in medical researches on the immunological process. In the present study, we investigated the polymorphisms of ULBP4/ RAET1E, a member of the ULBP/RAET1 family, and found 25 and 14 alleles from the rhesus and crab-eating macaques, respectively, of which diversities were far more extended than in humans. A phylogenetic study suggested that the allelic diversification of ULBP4/RAET1E predated the divergence of rhesus and crab-eating macaques. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
6. Impaired protective role of HLA-B*57:01/58:01 in HIV-1 CRF01_AE infection: a cohort study in Vietnam.
- Author
-
Minh, Tam Tran Thi, Hikichi, Yuta, Miki, Shoji, Imanari, Yuriko, Kusagawa, Shigeru, Okazaki, Midori, Thu, Thao Dang Thi, Shiino, Teiichiro, Matsuoka, Saori, Yamamoto, Hiroyuki, Ohashi, Jun, Hall, William W., Matano, Tetsuro, Thi, Lan Anh Nguyen, and Kawana-Tachikawa, Ai
- Subjects
- *
HIV , *HLA histocompatibility antigens , *VIETNAMESE people , *VIRAL load , *T cells - Abstract
• The protective effect of HLA-B*57:01/58:01 on HIV-1 CRF01_AE infection was examined. • The protective impact is impaired against CRF01_AE infection. • TW10-specific CD8+ T cells select for T242N even in CRF01_AE with viral fitness cost. • Less non-TW10 epitope presentation may contribute to the impaired protective impact. Human Leukocyte Antigen HLA-B*57:01 and B*58:01 are considered anti-HIV-1 protective alleles. HLA-B*57:01/58:01-restricted HIV-1 Gag TW10 (TSTLQEQIGW, Gag residues 240-249) epitope-specific CD8+ T cell responses that frequently select for a Gag escape mutation, T242N, with viral fitness cost are crucial for HIV-1 control. Although this finding has been observed in cohorts where HIV-1 subtype B or C predominates, the protective impact of HLA-B*57:01/58:01 has not been reported in Southeast Asian countries where HIV-1 CRF01_AE is the major circulating strain. Here, the effect of HLA-B*57:01/58:01 on CRF01_AE infection was investigated. The correlation of HLA-B*57:01/58:01 with viral load and CD4 counts were analyzed in the CRF01_AE-infected Vietnamese cohort (N = 280). The impact of the T242N mutation on CRF01_AE replication capacity was assessed. HLA-B*57:01/58:01 -positive individuals mostly had HIV-1 with T242N (62/63) but showed neither a significant reduction in viral load nor increased CD4 counts relative to B*57:01/58:01 -negative participants. In vitro and in vivo analyses revealed a significant reduction in viral fitness of CRF01_AE with T242N. In silico analysis indicated reduced presentation of epitopes in the context of CRF01_AE compared to subtype B or C in 10/16 HLA-B*57:01/58:01-restricted HIV-1 epitopes. The protective impact of HLA-B*57:01/58:01 on CRF01_AE infection is impaired despite strong suppressive pressure by TW10-specific CD8+ T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Neutralizing antibodies in SIV control: Co-impact with T cells
- Author
-
Yamamoto, Hiroyuki and Matano, Tetsuro
- Subjects
- *
SIMIAN viruses , *IMMUNOGLOBULINS , *T cells , *HIV , *RHESUS monkeys , *FOLLOW-up studies (Medicine) , *CELLULAR immunity , *VIREMIA , *AIDS vaccines , *IMMUNE response - Abstract
Abstract: Human immunodeficiency virus type 1 (HIV-1) and pathogenic simian immunodeficiency virus (SIV)-infected naïve hosts experience a characteristic absence of early and potent virus-specific neutralizing antibody (NAb) responses preceding establishment of persistent infection. Yet conversely, we have recently shown that NAbs passively immunized in rhesus macaques at early post-SIV challenge are capable of playing a critical role in non-sterile viremia control with implications of antibody-enhanced antigen presentation. In a current follow-up study we have further reported that NAbs mediate rapid elicitation of polyfunctional virus-specific CD4+ T-cells in vivo. The NAb-immunized macaques mounting these responses exhibited sustained viremia control for over 1 year, accompanied with robust anti-SIV cellular immunity. Perspectives obtained from the results are discussed. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
8. Hierarchy of multiple viral CD8+ T-cell epitope mutations in sequential selection in simian immunodeficiency infection.
- Author
-
Ntim, Nana Afia Asante, Ishii, Hiroshi, Jomori, Moe, Yamamoto, Hiroyuki, Matano, Tetsuro, and Nomura, Takushi
- Subjects
- *
T cells , *VIRAL mutation , *SIMIAN immunodeficiency virus , *CD8 antigen , *MAJOR histocompatibility complex - Abstract
CD8+ T-cell responses exert strong suppressive pressure on viral replication and select for viral escape mutations in HIV infection. Multiple viral epitopes restricted by major histocompatibility complex class I (MHC-I) are targeted by CD8+ T cells. Sequential selection of viral escape mutations in individual epitope-coding regions could result in failure in CD8+ T cell-based viral control leading to disease progression. However, how this sequential selection of epitope mutations occurs has not fully been determined. Here, we examined sequential selection of viral mutations in seven CD8+ T-cell epitope-coding regions in a macaque AIDS model of simian immunodeficiency virus mac239 (SIVmac239) infection. In seven SIVmac239-infected Burmese rhesus macaques possessing MHC-I haplotype 90-120-Ia , selection of viral mutations was observed in five to seven of the seven 90-120-Ia -associated CD8+ T-cell epitope-coding regions in a year post-infection. Of the seven CD8+ T-cell epitopes, viral mutation selection was detected first at two epitopes, Gag 206-216 and Nef 9-19 , but was found finally at Vif 114-124 epitope in most animals. Viral loads in 6 months were significantly associated with the number of mutated CD8+ T-cell epitope-coding regions 1 year post-infection. Tetramer analysis revealed early induction of Gag 241-249 specific CD8+ T-cell responses, which did not always result in early selection of viral mutations in the Gag 241-249 epitope, suggesting that the order of epitope mutation selection may not be determined only by immunodominance. This SIV infection model using 90-120-Ia -positive macaques would be useful for analysis of the determinants for sequential epitope mutation selection, contributing to our understanding of virus-host CD8+ T-cell interaction in HIV infection. • Sequential selection of CD8+ T-cell epitope mutations was examined in SIV infection. • Hierarchy of these epitope mutations in sequential selection was shown. • Higher viral load is associated with enhanced accumulation of viral mutations. • The order of epitope mutation selection is not determined only by immunodominance. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. IL-21-producer CD4+ T cell kinetics during primary simian immunodeficiency virus infection.
- Author
-
Shi, Shoi, Seki, Sayuri, Matano, Tetsuro, and Yamamoto, Hiroyuki
- Subjects
- *
INTERLEUKIN-21 , *T cells , *VIRUS diseases , *B cells , *SIMIAN immunodeficiency virus , *T helper cells - Abstract
Abstract: IL-21 signaling is important for T cell and B cell-mediated clearance of chronic viral infections. While non-cognate follicular helper CD4+ T cells (TFH) are indicated to be pivotal in providing IL-21-mediated help to activated B cells within germinal centers, how this signaling may be disrupted in early AIDS virus infection is not clear. In this study, we assessed the lineage and kinetics of peripheral blood IL-21-producing CD4+ T cells in primary simian immunodeficiency virus (SIV) infection of rhesus macaques. After SIV challenge, antigen-nonspecific IL-21 production was observed in Th1, Th2 and Th17 cells with Th1 dominance. While IL-21+ Th2 and IL-21+ Th17 showed variable kinetics, an increase in total IL-21+ CD4+ T cells and IL-21+ Th1 from week 3 to week 8 was observed, preceding plasma SIV-specific IgG development from week 5 to week 12. SIV Gag-specific IL-21+ CD4+ T cells detectable at week 2 were decreased in frequencies at week 5. Results imply that kinetics of IL-21+ CD4+ T cells comprised of multiple lineages, potentially targeted by SIV with a bias of existing frequencies during their precursor stage, associate with availability of cooperative B-cell help provided through a proportionate precursor pool developing into TFH and subsequent anti-SIV antibody responses. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
10. Determination of a T cell receptor of potent CD8+ T cells against simian immunodeficiency virus infection in Burmese rhesus macaques.
- Author
-
Ishii, Hiroshi, Matsuoka, Saori, Ikeda, Noriko, Kurihara, Kyoko, Ueno, Takamasa, Takiguchi, Masafumi, Naruse, Taeko K., Kimura, Akinori, Yokoyama, Masaru, Sato, Hironori, and Matano, Tetsuro
- Subjects
- *
SIMIAN immunodeficiency virus , *RHESUS monkeys , *T cells , *VIRUS diseases , *CELL determination , *MAJOR histocompatibility complex , *T cell receptors , *AIDS - Abstract
Cumulative studies on human immunodeficiency virus (HIV)-infected individuals have shown association of major histocompatibility complex class I (MHC-I) polymorphisms with lower viral load and delayed AIDS progression, suggesting that HIV replication can be controlled by potent CD8+ T-cell responses. We have previously established an AIDS model of simian immunodeficiency virus (SIV) infection in Burmese rhesus macaques and found a potent CD8+ T cell targeting the Mamu-A1*065:01-restricted Gag 241-249 epitope, which is located in a region corresponding to the HIV Gag 240-249 TW10 epitope restricted by a protective MHC-I allele, HLA-B*57. In the present study, we determined a T cell receptor (TCR) of this Gag 241-249 epitope-specific CD8+ T cell. cDNA clones encoding TCR-α and TCR-β chains were obtained from a Gag 241-249 -specific CD8+ T-cell clone. Coexpression of these TCR-α and TCR-β cDNAs resulted in reconstitution of a functional TCR specifically detected by Gag 241-249 epitope-Mamu-A1*065:01 tetramer. Two of three previously-reported CD8+ T-cell escape mutations reduced binding affinity of Gag 241-249 peptide to Mamu-A1*065:01 but the remaining one not. This is consistent with the data obtained by molecular modeling of the epitope-MHC-I complex and TCR. These results would contribute to understanding how viral CD8+ T-cell escape mutations are selected under structural constraint of viral proteins. • A T cell receptor (TCR) cDNA of potent SIV-specific CD8+ T cell was isolated. • This is the first determination of functional TCR in Burmese rhesus macaques. • Presentation and TCR interaction of mutant epitopes were analyzed. • This study facilitates understanding of the process of escape variant selection. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Control of Simian Immunodeficiency Virus Replication by Vaccine- Induced Gag- and Vif-Specific CD8+ T Cells.
- Author
-
Iwamoto, Nami, Takahashi, Naofumi, Seki, Sayuri, Nomura, Takushi, Yamamoto, Hiroyuki, Inoue, Makoto, Tsugumine Shu, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
- *
SIMIAN immunodeficiency virus , *VIRAL replication , *CD80 antigen , *T cells , *MAJOR histocompatibility complex , *AIDS vaccines - Abstract
For development of an effective T cell-based AIDS vaccine, it is critical to define the antigens that elicit the most potent responses. Recent studies have suggested that Gag-specific and possibly Vif/Nef-specific CD8+ T cells can be important in control of the AIDS virus. Here, we tested whether induction of these CD8+ T cells by prophylactic vaccination can result in control of simian immunodeficiency virus (SIV) replication in Burmese rhesus macaques sharing the major histocompatibility complex class I (MHC-I) haplotype 90-010-Ie associated with dominant Nef-specific CD8+ T-cell responses. In the first group vaccinated with Gag-expressing vectors (n=5 animals), three animals that showed efficient Gag-specific CD8+ T-cell responses in the acute phase postchallenge controlled SIV replication. In the second group vaccinated with Vif- and Nef-expressing vectors (n=6 animals), three animals that elicited Vif-specific CD8+ T-cell responses in the acute phase showed SIV control, whereas the remaining three with Nef-specific but not Vif-specific CD8+ T-cell responses failed to control SIV replication. Analysis of 18 animals, consisting of seven unvaccinated noncontrollers and the 11 vaccinees described above, revealed that the sum of Gag- and Vifspecific CD8+ T-cell frequencies in the acute phase was inversely correlated with plasma viral loads in the chronic phase. Our results suggest that replication of the AIDS virus can be controlled by vaccine-induced subdominant Gag/Vif epitope-specific CD8+ T cells, providing a rationale for the induction of Gag- and/or Vif-specific CD8+ T-cell responses by prophylactic AIDS vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Immunogenicity of repeated Sendai viral vector vaccination in macaques
- Author
-
Kurihara, Kyoko, Takahara, Yusuke, Nomura, Takushi, Ishii, Hiroshi, Iwamoto, Nami, Takahashi, Naofumi, Inoue, Makoto, Iida, Akihiro, Hara, Hiroto, Shu, Tsugumine, Hasegawa, Mamoru, Moriya, Chikaya, and Matano, Tetsuro
- Subjects
- *
SENDAI virus diseases , *VIRAL vaccines , *MACAQUES , *IMMUNE response , *GENETIC vectors , *CELLULAR immunity , *T cells , *IMMUNOGLOBULINS , *SIMIAN immunodeficiency virus , *HAPLOTYPES - Abstract
Abstract: Induction of durable cellular immune responses by vaccination is an important strategy for the control of persistent pathogen infection. Viral vectors are promising vaccine tools for eliciting antigen-specific T-cell responses. Repeated vaccination may contribute to durable memory T-cell induction, but anti-vector antibodies could be an obstacle to its efficacy. We previously developed a Sendai virus (SeV) vector vaccine and showed the potential of this vector for efficient T-cell induction in macaques. Here, we examined whether repeated SeV vector vaccination with short intervals can enhance antigen-specific CD8+ T-cell responses. Four rhesus macaques possessing the MHC-I haplotype 90-120-Ia were immunized three times with intervals of three weeks. For the vaccination, we used replication-defective F-deleted SeV vectors inducing CD8+ T-cell responses specific for simian immunodeficiency virus Gag206–216 and Gag241–249, which are dominant epitopes restricted by 90-120-Ia-derived MHC-I molecules. All four animals showed higher Gag206–216-specific and Gag241–249-specific CD8+ T-cell responses after the third vaccination than those after the first vaccination, indicating enhancement of antigen-specific CD8+ T-cell responses by the second/third SeV vector vaccination even with short intervals. These results suggest that repeated SeV vector vaccination can contribute to induction of efficient and durable T-cell responses. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
13. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge
- Author
-
Takahara, Yusuke, Matsuoka, Saori, Kuwano, Tetsuya, Tsukamoto, Tetsuo, Yamamoto, Hiroyuki, Ishii, Hiroshi, Nakasone, Tadashi, Takeda, Akiko, Inoue, Makoto, Iida, Akihiro, Hara, Hiroto, Shu, Tsugumine, Hasegawa, Mamoru, Sakawaki, Hiromi, Horiike, Mariko, Miura, Tomoyuki, Igarashi, Tatsuhiko, Naruse, Taeko K., Kimura, Akinori, and Matano, Tetsuro
- Subjects
- *
T cells , *AIDS vaccines , *HIV , *VIRAL replication , *VACCINES , *ANTINEOPLASTIC antibiotics , *SIV antibodies , *ANTIGENS - Abstract
Abstract: Cytotoxic T lymphocyte (CTL) responses are crucial for the control of human and simian immunodeficiency virus (HIV and SIV) replication. A promising AIDS vaccine strategy is to induce CTL memory resulting in more effective CTL responses post-viral exposure compared to those in natural HIV infections. We previously developed a CTL-inducing vaccine and showed SIV control in some vaccinated rhesus macaques. These vaccine-based SIV controllers elicited vaccine antigen-specific CTL responses dominantly in the acute phase post-challenge. Here, we examined CTL responses post-challenge in those vaccinated animals that failed to control SIV replication. Unvaccinated rhesus macaques possessing the major histocompatibility complex class I haplotype 90-088-Ij dominantly elicited SIV non-Gag antigen-specific CTL responses after SIV challenge, while those induced with Gag-specific CTL memory by prophylactic vaccination failed to control SIV replication with dominant Gag-specific CTL responses in the acute phase, indicating dominant induction of vaccine antigen-specific CTL responses post-challenge even in non-controllers. Further analysis suggested that prophylactic vaccination results in dominant induction of vaccine antigen-specific CTL responses post-viral exposure but delays SIV non-vaccine antigen-specific CTL responses. These results imply a significant influence of prophylactic vaccination on CTL immunodominance post-viral exposure, providing insights into antigen design in development of a CTL-inducing AIDS vaccine. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
14. 761. Genotoxicity Free Intranasal Gene Vaccines for Alzheimer's Disease and AIDS with Remarkable Efficacy in Model Animals; Use of a Cytoplasmic RNA Vector, Sendai Virus Vectors.
- Author
-
Inoue, Makoto, Hara, Hideo, Matano, Tetsuro, Tokusumi, Yumiko, Yonemitsu, Yoshikazu, Kurosawa, Natsuko, Kanaya, Takumi, Hironaka, Takashi, Nagai, Yoshiyuki, Tabira, Takeshi, and Hasegawa, Mamoru
- Subjects
- *
ALZHEIMER'S disease , *LYMPHOCYTES , *NEURODEGENERATION , *T cells , *SENDAI virus , *IMMUNIZATION , *GENETIC engineering - Abstract
The cytoplasmic RNA vector would be promising for use in gene vaccines to large population of patients or infected persons in urgent or in hospitals of various conditions because of its important genotoxicity-free nature. The candidate intranasal gene vaccines have been developed using Sendai virus (SeV) vector for both infectious and neurodegenerative diseases such as AIDS and Alzheimer's disease (AD), respectively. SeV belonging to the Genus Respirovirus, infects and multiplies its genome copy in most mammalian cells. Its replication is strictly in cytoplasm and independent of nuclear functions of host cells. Moreover, SeV does not have a DNA phase during its life cycle, so SeV-based vectors that express high-level of transgene do not need to be concerned about the transformation of cells by integration of vector materials into the host chromosomes. These properties of the vector enable us to propose the new concepts, CYTOPLASMIC GENE THERAPY and CYTOPLASMIC VACCINATION with RNP-based treatment.For the treatment of AD, the F gene-deleted non-transmissible SeV (SeV/ΔF) vector carrying amyloid-β (Aβ) gene was used. According to the “Amyloid Cascade Theory”, the formation of senile plaques through aggregation and deposition of Aβ peptides in the brain is considered as a major cause of the disease. Thus, immune-mediated strategy known as Aβ vaccination has been thought to be a promising therapeutic approach for the treatment of Alzheimer's disease. Single intranasal administration of SeV vector carrying Aβ gene (Aβ 1–43) to the 24 to 25-month-old APP transgenic mice induced the expression of the Aβ peptide in the epithelial cells of the nasal mucosa. Serum antibody level was elevated and the amyloid burdens in the brain were decreased to 10–20% of the control mice after eight weeks treatment. Importantly, no lymphocytes infiltration that into the central nervous system was detected.For the AIDS vaccine, the Gag-expressing SeV/ΔF vector was used. Macaques vaccinated with DNA-prime/Gag-expressing SeV/ΔF-boost were challenged intravenously with the pathogenic simian immunodeficiency virus (SIVmac239) that induces chronic disease progression. The SeV boost induced Gag-specific CD4+ T cells, and its level in peripheral T lymphocytes was maintained for more than 40 weeks. The vaccine-induced cytotoxic T lymphocytes (CTLs) controlled SIVmac239 replication well. Thus, the mucosal immunotherapy with SeV vector has the great potential of prevention and treatment for both infectious and neurodegenerative diseases and might be a novel, attractive approach in gene vaccines of coming age.Molecular Therapy (2006) 13, S294–S295; doi: 10.1016/j.ymthe.2006.08.845 [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
15. Impact of Cytotoxic-T-Lymphocyte Memory Induction without Virus-Specific CD4+ T-Cell Help on Control of a Simian Immunodeficiency Virus Challenge in Rhesus Macaques.
- Author
-
Tsukamoto, Tetsuo, Takeda, Akiko, Yamamoto, Takuya, Yamamoto, Hiroyuki, Kawada, Miki, and Matano, Tetsuro
- Subjects
- *
SIMIAN viruses , *LYMPHOCYTES , *AIDS vaccines , *HIV prevention , *T cells , *SENDAI virus , *ANTIBODY-dependent cell cytotoxicity - Abstract
Despite many efforts to develop AIDS vaccines eliciting virus-specific T-cell responses, whether induction of these memory T cells by vaccination before human immunodeficiency virus (HIV) exposure can actually contribute to effective T-cell responses postinfection remains unclear. In particular, induction of HIV-specific memory CD4+ T cells may increase the target cell pool for HIV infection because the virus preferentially infects HIV-specific CD4+ T cells. However, virus-specific CD4+ helper T-cell responses are thought to be important for functional CD8+ cytotoxic-T-lymphocyte (CTL) induction in HIV infection, and it has remained unknown whether HIV-specific memory CD8+ T cells induced by vaccination without HIV-specific CD4+ T-cell help can exert effective responses after virus exposure. Here we show the impact of CD8+ T-cell memory induction without virus-specific CD4+ T-cell help on the control of a simian immunodeficiency virus (SIV) challenge in rhesus macaques. We developed a prophylactic vaccine by using a Sendai virus (SeV) vector expressing a single SIV Gag241-249 CTL epitope fused with enhanced green fluorescent protein (EGFP). Vaccination resulted in induction of SeV-EGFP-specific CD4+ T-cell and Gag241-249-specific CD8+ T-cell responses. After a SIV challenge, the vaccinees showed dominant Gag241-249-specific CD8+ T-cell responses with higher effector memory frequencies in the acute phase and exhibited significantly reduced viral loads. These results demonstrate that virus-specific memory CD8+ T cells induced by vaccination without virus-specific CD4+ T-cell help could indeed facilitate SIV control after virus exposure, indicating the benefit of prophylactic vaccination eliciting virus-specific CTL memory with non-virus-specific CD4+ T-cell responses for HIV control. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
16. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques
- Author
-
Takeda, Akiko, Igarashi, Hiroko, Kawada, Miki, Tsukamoto, Tetsuo, Yamamoto, Hiroyuki, Inoue, Makoto, Iida, Akihiro, Shu, Tsugumine, Hasegawa, Mamoru, and Matano, Tetsuro
- Subjects
- *
PRIMATE diseases , *VIRAL vaccines , *SENDAI virus , *VIRAL replication , *DRUG delivery devices , *T cells , *IMMUNIZATION , *MEDICAL protocols , *ANTIGENS , *AIDS vaccines , *VACCINATION - Abstract
Abstract: Viral vectors are promising vaccine tools for eliciting antigen-specific T-cell responses. We previously showed the potential of recombinant Sendai virus (SeV) vectors to induce virus-specific T-cell responses in macaque AIDS models. Here, we have evaluated the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted SeV vectors in macaques. Intranasal replication-competent and replication-defective SeV immunizations both elicited robust systemic antigen-specific T-cell responses, whereas the responses induced by the former were more durable than those by the latter. However, even the latter-induced T-cell responses remained detectable in a local, retropharyngeal lymph node two months after the immunization. These findings are useful for establishment of a vaccine protocol using SeV vectors. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
17. Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques
- Author
-
Moriya, Chikaya, Horiba, Satoshi, Inoue, Makoto, Iida, Akihiro, Hara, Hiroto, Shu, Tsugumine, Hasegawa, Mamoru, and Matano, Tetsuro
- Subjects
- *
ANTIGENS , *IMMUNE response , *T cells , *IMMUNOGLOBULINS - Abstract
Abstract: Recombinant viral vectors are promising vaccine tools for eliciting potent cellular immune responses against immunodeficiency virus infection, but pre-existing anti-vector antibodies can be an obstacle to their clinical use in humans. We have previously vaccinated rhesus macaques with a recombinant Sendai virus (SeV) vector twice at an interval of more than 1 year and have shown efficient antigen-specific T-cell induction by the second as well as the first vaccination. Here, we have established the method for measurement of SeV-specific neutralizing titers and have found efficient SeV-specific neutralizing antibody responses just before the second SeV vaccination in these macaques. This suggests the feasibility of inducing antigen-specific T-cell responses by SeV vaccination even in the host with pre-existing anti-SeV neutralizing antibodies. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
18. Involvement of Multiple Epitope-Specific Cytotoxic T-Lymphocyte Responses in Vaccine-Based Control of Simian Immunodeficiency Virus Replication in Rhesus Macaques.
- Author
-
Kawada, Miki, Igarashi, Hiroko, Takeda, Akiko, Tsukamoto, Tetsuo, Yamamoto, Hiroyuki, Dohki, Sachi, Takiguchi, Masafumi, and Matano, Tetsuro
- Subjects
- *
T cells , *VIRAL vaccines , *VIRAL replication , *CELL-mediated cytotoxicity , *MAJOR histocompatibility complex , *HLA histocompatibility antigens , *HIV - Abstract
Cytotoxic T-lymphocyte (CTL) responses are crucial for the control of immunodeficiency virus replication. Possible involvement of a dominant single epitope-specific CTL in control of viral replication has recently been indicated in preclinical AIDS vaccine trials, but it has remained unclear if multiple epitope-specific CTLs can be involved in the vaccine-based control. Here, by following up five rhesus macaques that showed vaccine-based control of primary replication of a simian immunodeficiency virus, SIVmac239, we present evidence indicating involvement of multiple epitope-specific CTL responses in this control. Three macaques maintained control for more than 2 years without additional mutations in the provirus. However, in the other two that shared a major histocompatibility complex haplotype, viral mutations were accumulated in a similar order, leading to viral evasion from three epitope-specific CTL responses with viral fitness costs. Accumulation of these multiple escape mutations resulted in the reappearance of plasma viremia around week 60 after challenge. Our results implicate multiple epitope-specific CTL responses in control of immunodeficiency virus replication and furthermore suggest that sequential accumulation of multiple CTL escape mutations, if allowed, can result in viral evasion from this control. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
19. Reversion In Vivo after Inoculation of a Molecular Proviral DNA Clone of Simian Immunodeficiency Virus with a Cytotoxic-T-Lymphocyte Escape Mutation.
- Author
-
Kobayashi, Masahiro, Igarashi, Hiroko, Takeda, Akiko, Kato, Moriaki, and Matano, Tetsuro
- Subjects
- *
SIMIAN viruses , *VIRAL replication , *T cells , *GENETIC mutation , *MOLECULAR cloning , *MACAQUES - Abstract
Vaccine-based control of the replication of a simian immunodeficiency virus (SIV), SIVmac239, in macaques has recently been shown. In the process of the control, a mutant virus escaping from epitope-specific cytotoxic-T-lymphocyte (CTL) responses was rapidly selected and contained. In this study, we show that the wild-type virus appeared and became predominant in the absence of the epitope-specific CTL after inoculation of naive macaques with a molecular clone DNA of the CTL escape mutant SIV. This is the first report describing reversion in vivo from an inoculated, molecular proviral DNA clone of immunodeficiency virus with a CTL escape mutation. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
20. Polyfunctional CD4+ T-Cell Induction in Neutralizing Antibody-Triggered Control of Simian Immunodeficiency Virus Infection.
- Author
-
Yamamoto, Takuya, Iwamoto, Nami, Yamamoto, Hiroyuki, Tsukamoto, Tetsuo, Kuwano, Tetsuya, Takeda, Akiko, Kawada, Miki, Tsunetsugu-Yokota, Yasuko, and Matano, Tetsuro
- Subjects
- *
SIMIAN viruses , *IMMUNODEFICIENCY , *VIRUS diseases , *T cells , *TUMOR necrosis factors , *RHESUS monkeys - Abstract
Rapid depletion of memory CD4+ T cells and delayed induction of neutralizing antibody (NAb) responses are characteristics of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Although it was speculated that postinfection NAb induction could have only a limited suppressive effect on primary HIV replication, a recent study has shown that a single passive NAb immunization of rhesus macaques 1 week after SIV challenge can result in reduction of viral loads at the set point, indicating a possible contribution of postinfection NAb responses to virus control. However, the mechanism accounting for this NAb-triggered SIV control has remained unclear. Here, we report rapid induction of virus-specific polyfunctional T-cell responses after the passive NAb immunization postinfection. Analysis of SIV Gag-specific responses of gamma interferon, tumor necrosis factor alpha, interleukin-2, macrophage inflammatory protein 1β, and CD107a revealed that the polyfunctionality of Gag-specific CD4+ T cells, as defined by the multiplicity of these responses, was markedly elevated in the acute phase in NAb-immunized animals. In the chronic phase, despite the absence of detectable NAbs, virus control was maintained, accompanied by polyfunctional Gag-specific T-cell responses. These results implicate virus-specific polyfunctional CD4+ T-cell responses in this NAb-triggered virus control, suggesting possible synergism between NAbs and T cells for control of HIV/SIV replication. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
21. Transmission of Simian Immunodeficiency Virus Carrying Multiple Cytotoxic T-Lymphocyte Escape Mutations with Diminished Replicative Ability Can Result in AIDS Progression in Rhesus Macaques.
- Author
-
Seki, Sayuri, Kawada, Miki, Takeda, Akiko, Igarashi, Hiroko, Sata, Tetsutaro, and Matano, Tetsuro
- Subjects
- *
SIMIAN viruses , *T cells , *VIRAL replication , *AIDS , *RHESUS monkeys , *MAJOR histocompatibility complex , *INFECTIOUS disease transmission - Abstract
Cytotoxic T-lymphocyte (CTL) responses frequently select for immunodeficiency virus mutations that result in escape from CTL recognition with viral fitness costs. The replication in vivo of such viruses carrying not single but multiple escape mutations in the absence of the CTL pressure has remained undetermined. Here, we have examined the replication of simian immunodeficiency virus (SIV) with five gag mutations selected in a macaque possessing the major histocompatibility complex haplotype 90-120-Ia after its transmission into 90-120-Ia-negative macaques. Our results showed that even such a "crippled" SIV infection can result in persistent viral replication, multiple reversions, and AIDS progression. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
22. Induction of CD8+ Cells Able To Suppress CCR5-Tropic Simian Immunodeficiency Virus SIVmac239 Replication by Controlled Infection of CXCR4-Tropic Simian-Human Immunodeficiency Virus in Vaccinated Rhesus Macaques.
- Author
-
Tsukamoto, Tetsuo, Yuasa, Mitsuhiro, Yamamoto, Hiroyuki, Kawada, Miki, Takeda, Akiko, Igarashi, Hiroko, and Matano, Tetsuro
- Subjects
- *
T cells , *SIMIAN viruses , *HIV , *VIRAL replication , *AIDS vaccines , *VACCINATION , *MACAQUES - Abstract
Recent recombinant viral vector-based AIDS vaccine trials inducing cellular immune responses have shown control of CXCR4-tropic simian-human immunodeficiency virus (SHIV) replication but difficulty in containment of pathogenic CCR5-tropic simian immunodeficiency virus (SIV) in rhesus macaques. In contrast, controlled infection of live attenuated SIV/SHIV can confer the ability to contain SIV superchallenge in macaques. The specific immune responses responsible for this control may be induced by live virus infection but not consistently by viral vector vaccination, although those responses have not been determined. Here, we have examined in vitro anti-SIV efficacy of CD8+ cells in rhesus macaques that showed prophylactic viral vector vaccine-based control of CXCR4-tropic SHIV89.6PD replication. Analysis of the effect of CD8+ cells obtained at several time points from these macaques on CCR5-tropic SIVmac239 replication in vitro revealed that CD8+ cells in the chronic phase after SHIV challenge suppressed SIV replication more efficiently than those before challenge. SIVmac239 superchallenge of two of these macaques at 3 or 4 years post-SHIV challenge was contained, and the following anti-CD8 antibody administration resulted in transient CD8+ T-cell depletion and appearance of plasma SIVmac239 viremia in both of them. Our results indicate that CD8+ cells acquired the ability to efficiently suppress SIV replication by controlled SHIV infection, suggesting the contribution of CD8+ cell responses induced by controlled live virus infection to containment of HIV/SIV superinfection. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
23. Long-Term Control of Simian Immunodeficiency Virus Replication with Central Memory CD4+ T-Cell Preservation after Nonsterile Protection by a Cytotoxic T-Lymphocyte-Based Vaccine.
- Author
-
Kawada, Miki, Tsukamoto, Tetsuo, Yamamoto, Hiroyuki, Takeda, Akiko, Igarashi, Hiroko, Watkins, David I., and Matano, Tetsuro
- Subjects
- *
T cells , *AIDS prevention , *VACCINATION , *MACAQUES , *ANTIGENS , *IMMUNOGLOBULINS - Abstract
Induction of virus-specific CD8+ cytotoxic T-lymphocyte (CTL) responses is a promising strategy for AIDS vaccine development. However, it has remained unclear if or how long-term viral containment and disease control are attainable by CTL-based nonsterile protection. Here, we present three rhesus macaques that successfully maintained Env-independent vaccine-based control of simian immunodeficiency virus (SIV) mac239 replication without disease progression for more than 3 years. SIV-specific neutralizing antibody induction was inefficient in these controllers. Vaccine-induced Gag-specific CTLs were crucial for the chronic as well as the primary viral control in one of them, whereas those Gag-specific CTL responses became undetectable and CTLs specific for SIV antigens other than Gag, instead, became predominant in the chronic phase in the other two controllers. A transient CD8+ cell depletion experiment 3 years postinfection resulted in transient reappearance of plasma viremia in these two animals, suggesting involvement of the SIV non-Gag-specific CTLs in the chronic SIV control. This sustained, neutralizing antibody-independent viral control was accompanied with preservation of central memory CD4+ T cells in the chronic phase. Our results suggest that prophylactic CTL vaccine-based nonsterile protection can result in long-term viral containment by adapted CTL responses for AIDS prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.